SXTP
60 Degrees Pharmaceuticals, Inc.
Price Chart
Latest Quote
$1.64
+0.02 (+1.23%)
Current Price
| Previous Close | $1.62 |
| Open | $1.57 |
| Day High | $1.68 |
| Day Low | $1.57 |
| Volume | 92,143 |
Stock Information
| Shares Outstanding | 2.66M |
| Total Debt | $152K |
| Cash Equivalents | $3.34M |
| Revenue | $1.31M |
| Net Income | $-8.09M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $4.36M |
| EPS (TTM) | $-6.76 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $10.18M |
| Sales | $1.31M |
| Income | $-8.09M |
| Book/sh | $-1.80 |
| Cash/sh | $1.26 |
| Employees | 3 |
Financial Ratios
| Quick Ratio | 1.96 |
| Current Ratio | 3.34 |
| Debt/Eq | 3.20 |
Returns & Margins
| ROA | -77.92% |
| ROE | -172.82% |
| Gross Margin | -113.78% |
| Operating Margin | -1292.45% |
Ownership
| Insider Ownership | 0.88% |
| Institutional Ownership | 9.60% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.46 |
| P/S | 3.32 |
| P/B | -0.91 |
Analyst Data
| Recommendation | none |
| Target Price | $3.70 |
Technical Indicators
| SMA20 | $1.47 |
| SMA50 | $1.58 |
| SMA200 | $3.36 |
| RSI | 61.19 |
| ATR | 0.1234 |
| Shares Float | 2.44M |
| Short Float | 4.95% |
| Short Ratio | 2.19 |
| Volatility | 2.65 |
| Rel Volume | 0.67 |
Performance History
| Week | +18.84% |
| Month | +16.31% |
| Quarter | -15.03% |
| 6 Months | -50.60% |
| YTD | -20.54% |
| Year | -80.19% |
| 10 Years | -99.85% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.64 | 92,143 |
| 2026-06-17 | $1.62 | 222,500 |
| 2026-06-16 | $1.46 | 41,400 |
| 2026-06-15 | $1.49 | 85,700 |
| 2026-06-12 | $1.36 | 92,700 |
| 2026-06-11 | $1.38 | 1,413,400 |
| 2026-06-10 | $1.38 | 20,600 |
| 2026-06-09 | $1.39 | 74,400 |
| 2026-06-08 | $1.43 | 21,400 |
| 2026-06-05 | $1.42 | 38,700 |
| 2026-06-04 | $1.53 | 65,400 |
| 2026-06-03 | $1.45 | 54,300 |
| 2026-06-02 | $1.47 | 38,800 |
| 2026-06-01 | $1.46 | 30,700 |
| 2026-05-29 | $1.49 | 14,900 |
| 2026-05-28 | $1.49 | 49,100 |
| 2026-05-27 | $1.41 | 43,500 |
| 2026-05-26 | $1.50 | 248,600 |
| 2026-05-22 | $1.48 | 49,600 |
| 2026-05-21 | $1.49 | 59,800 |
| 2026-05-20 | $1.40 | 63,800 |
| 2026-05-19 | $1.41 | 27,200 |
About 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.
đ° Latest News
Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-13T21:15:02Z
Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-11T13:10:03Z
60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know
Zacks âĸ 2026-04-03T16:00:01Z
60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA
Insider Monkey âĸ 2026-02-24T18:10:37Z
Is GoodRx (GDRX) Using ARAKODA Discounts To Quietly Redefine Its Preventive Care Strategy?
Simply Wall St. âĸ 2026-02-08T02:05:13Z
Sector Update: Health Care Stocks Mixed Late Afternoon
MT Newswires âĸ 2026-01-22T20:54:59ZTop Midday Gainers
MT Newswires âĸ 2026-01-22T18:58:08ZSector Update: Health Care Stocks Rise in Afternoon Trading
MT Newswires âĸ 2026-01-22T18:51:17ZWall Street Set to Open Higher Thursday as Investors Parse GDP, Unemployment Data, Look Ahead to Inflation Report
MT Newswires âĸ 2026-01-22T14:25:55ZInvestors Await Raft of Key Economic Data as US Futures Rise Thursday Pre-Bell
MT Newswires âĸ 2026-01-22T13:13:26Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $781,695 | $384,765 | $474,550 | $432,370 |
| Cost Of Revenue | $781,695 | $384,765 | $474,550 | $432,370 |
| Total Revenue | $1,005,471 | $607,574 | $253,573 | $223,208 |
| Operating Revenue | $1,005,471 | $607,574 | $253,573 | $223,208 |
| Expenses | ||||
| Interest Expense | $7,805 | $7,912 | $2,286,637 | $3,989,359 |
| Total Expenses | $8,764,050 | $10,322,755 | $5,408,156 | $1,973,653 |
| Other Income Expense | $398,059 | $1,767,430 | $3,627,670 | $-437,480 |
| Other Non Operating Income Expenses | $131,970 | $101,464 | $5,296,153 | $-43,238 |
| Net Non Operating Interest Income Expense | $-7,805 | $-7,912 | $-2,286,637 | $-3,989,359 |
| Interest Expense Non Operating | $7,805 | $7,912 | $2,286,637 | $3,989,359 |
| Operating Expense | $7,982,355 | $9,937,990 | $4,933,606 | $1,541,283 |
| Other Operating Expenses | $-403,624 | $-73,771 | - | $-288,002 |
| General And Administrative Expense | $6,279,823 | $5,025,235 | $4,241,836 | $1,303,722 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-7,365,158 | $-7,947,107 | $-3,765,702 | $-6,181,720 |
| Net Interest Income | $-7,805 | $-7,912 | $-2,286,637 | $-3,989,359 |
| Normalized Income | $-7,631,247 | $-9,613,073 | $-2,447,600 | $-5,870,269 |
| Net Income From Continuing And Discontinued Operation | $-7,365,158 | $-7,947,107 | $-3,765,702 | $-6,181,720 |
| Total Operating Income As Reported | $-7,758,579 | $-9,715,181 | $-5,154,583 | $-1,750,445 |
| Net Income Common Stockholders | $-7,365,158 | $-7,947,107 | $-3,765,702 | $-6,181,720 |
| Net Income | $-7,365,158 | $-7,947,107 | $-3,765,702 | $-6,181,720 |
| Net Income Including Noncontrolling Interests | $-7,368,325 | $-7,955,663 | $-3,813,800 | $-6,177,784 |
| Net Income Continuous Operations | $-7,368,325 | $-7,955,663 | $-3,813,800 | $-6,177,784 |
| Pretax Income | $-7,368,325 | $-7,955,663 | $-3,813,550 | $-6,177,284 |
| Operating Income | $-7,758,579 | $-9,715,181 | $-5,154,583 | $-1,750,445 |
| Gross Profit | $223,776 | $222,809 | $-220,977 | $-209,162 |
| Special Income Charges | - | $0 | $-1,231,480 | $120,683 |
| Per Share | ||||
| Diluted EPS | $-11.73 | $-74.17 | $-236.72 | $-266.38 |
| Basic EPS | $-11.73 | $-74.17 | $-236.72 | $-266.38 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $-350,381 | $-82,791 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-7,543,737 | $-9,549,972 | $241,942 | $-1,714,897 |
| Total Unusual Items | $266,089 | $1,665,966 | $-1,668,483 | $-394,242 |
| Total Unusual Items Excluding Goodwill | $266,089 | $1,665,966 | $-1,668,483 | $-394,242 |
| Reconciled Depreciation | $82,872 | $63,745 | $100,372 | $78,786 |
| EBITDA (Bullshit earnings) | $-7,277,648 | $-7,884,006 | $-1,426,541 | $-2,109,139 |
| EBIT | $-7,360,520 | $-7,947,751 | $-1,526,913 | $-2,187,925 |
| Diluted Average Shares | $1,163,142 | $107,147 | $16,578 | $23,206 |
| Basic Average Shares | $1,163,142 | $107,147 | $16,578 | $23,206 |
| Diluted NI Availto Com Stockholders | $-7,365,158 | $-7,947,107 | $-3,765,702 | $-6,181,720 |
| Minority Interests | $3,167 | $8,556 | $48,098 | $-3,936 |
| Tax Provision | $0 | $0 | $250 | $500 |
| Gain On Sale Of Security | $266,089 | $1,665,966 | $-437,003 | $-514,925 |
| Research And Development | $2,106,156 | $4,986,526 | $691,770 | $525,563 |
| Selling General And Administration | $6,279,823 | $5,025,235 | $4,241,836 | $1,303,722 |
| Other Gand A | $6,279,823 | $5,025,235 | $4,241,836 | $1,303,722 |
| Other Special Charges | - | - | $1,231,480 | $-120,683 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,238,816 | $3,878,516 | $4,642,876 | $-23,740,995 |
| Total Assets | $5,366,211 | $5,759,345 | $7,783,771 | $1,297,206 |
| Total Non Current Assets | $470,726 | $373,068 | $541,183 | $198,202 |
| Non Current Prepaid Assets | $0 | $66,176 | $242,647 | $0 |
| Goodwill And Other Intangible Assets | $224,361 | $157,084 | $227,258 | $164,255 |
| Other Intangible Assets | $224,361 | $157,084 | $227,258 | $164,255 |
| Current Assets | $4,895,485 | $5,386,277 | $7,242,588 | $1,099,004 |
| Other Current Assets | $978,131 | $1,068,940 | $4,402,602 | $200,967 |
| Current Deferred Assets | $1,240,721 | $1,728,472 | $0 | $68,629 |
| Inventory | $656,924 | $442,764 | $466,169 | $518,578 |
| Receivables | $509,644 | $486,748 | $231,332 | $45,965 |
| Accounts Receivable | $509,644 | $486,748 | $231,332 | $45,965 |
| Cash Cash Equivalents And Short Term Investments | $1,510,065 | $1,659,353 | $2,142,485 | $264,865 |
| Cash And Cash Equivalents | $1,510,065 | $1,659,353 | $2,142,485 | $264,865 |
| Cash Financial | $1,510,065 | $1,659,353 | $2,142,485 | $264,865 |
| Prepaid Assets | - | - | - | $200,967 |
| Debt | ||||
| Total Debt | $152,775 | $155,891 | $172,673 | $22,418,301 |
| Long Term Debt And Capital Lease Obligation | $144,003 | $147,119 | $150,251 | $1,270,055 |
| Long Term Debt | $144,003 | $147,119 | $150,251 | $1,270,055 |
| Current Debt And Capital Lease Obligation | $8,772 | $8,772 | $22,422 | $21,148,246 |
| Current Debt | $8,772 | $8,772 | $8,772 | $21,135,246 |
| Other Current Borrowings | $8,772 | $8,772 | $8,772 | $16,858,637 |
| Net Debt | - | - | - | $22,140,436 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,986,795 | $1,804,339 | $2,985,675 | $25,446,266 |
| Total Non Current Liabilities Net Minority Interest | $144,003 | $147,119 | $150,251 | $1,525,055 |
| Current Liabilities | $1,842,792 | $1,657,220 | $2,835,424 | $23,921,211 |
| Other Current Liabilities | $374,741 | $640,830 | $2,306,796 | $1,494,200 |
| Payables And Accrued Expenses | $1,459,279 | $1,007,618 | $506,206 | $953,765 |
| Payables | $1,459,279 | $1,007,618 | $506,206 | $953,765 |
| Accounts Payable | $1,459,279 | $1,007,618 | $506,206 | $758,668 |
| Non Current Deferred Liabilities | - | - | $0 | $255,000 |
| Current Deferred Liabilities | - | - | $0 | $325,000 |
| Current Notes Payable | - | - | $0 | $4,276,609 |
| Tradeand Other Payables Non Current | - | - | - | - |
| Other Payable | - | - | - | - |
| Total Tax Payable | - | - | - | - |
| Income Tax Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $-6,104,262 | $-5,531,839 | $-4,987,906 | $-23,576,740 |
| Preferred Stock Equity | $9,567,439 | $9,567,439 | $9,858,040 | - |
| Total Equity Gross Minority Interest | $3,379,416 | $3,955,006 | $4,798,096 | $-24,149,060 |
| Stockholders Equity | $3,463,177 | $4,035,600 | $4,870,134 | $-23,576,740 |
| Gains Losses Not Affecting Retained Earnings | $142,598 | $135,471 | $135,561 | $73,708 |
| Other Equity Adjustments | $142,598 | $135,471 | $135,561 | $73,708 |
| Retained Earnings | $-47,893,115 | $-40,527,957 | $-32,580,850 | $-28,815,148 |
| Other | ||||
| Ordinary Shares Number | $1,163,142 | $141,727 | $24,208 | $23,206 |
| Share Issued | $1,163,142 | $141,727 | $24,208 | $23,206 |
| Tangible Book Value | $-6,328,623 | $-5,688,923 | $-5,215,164 | $-23,740,995 |
| Invested Capital | $-5,951,487 | $-5,375,948 | $-4,828,883 | $-1,171,439 |
| Working Capital | $3,052,693 | $3,729,057 | $4,407,164 | $-22,822,207 |
| Total Capitalization | $3,607,180 | $4,182,719 | $5,020,385 | $-22,306,685 |
| Minority Interest | $-83,761 | $-80,594 | $-72,038 | $-572,320 |
| Additional Paid In Capital | $41,646,139 | $34,860,633 | $27,457,373 | $5,164,461 |
| Capital Stock | $9,567,555 | $9,567,453 | $9,858,050 | $239 |
| Common Stock | $116 | $14 | $10 | $239 |
| Preferred Stock | $9,567,439 | $9,567,439 | $9,858,040 | $0 |
| Net PPE | $246,365 | $149,808 | $71,278 | $33,947 |
| Accumulated Depreciation | $-190,854 | $-149,433 | $-148,064 | $-126,902 |
| Gross PPE | $437,219 | $299,241 | $219,342 | $160,849 |
| Other Properties | $366,791 | $233,411 | $146,428 | $145,558 |
| Machinery Furniture Equipment | $70,428 | $65,830 | $72,914 | $15,291 |
| Inventories Adjustments Allowances | $-251,677 | $0 | $0 | $-160,338 |
| Finished Goods | $385,982 | $157,881 | $187,182 | $183,943 |
| Work In Process | $446,957 | $284,883 | $278,987 | $97,486 |
| Raw Materials | $75,662 | $0 | $0 | $397,487 |
| Capital Lease Obligations | - | $0 | $13,650 | $13,000 |
| Current Capital Lease Obligation | - | $0 | $13,650 | $13,000 |
| Non Current Deferred Revenue | - | - | $0 | $255,000 |
| Current Deferred Revenue | - | - | $0 | $325,000 |
| Dueto Related Parties Current | - | - | $0 | $195,097 |
| Long Term Capital Lease Obligation | - | - | - | $0 |
| Dueto Related Parties Non Current | - | - | - | - |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-7,067,106 | $-5,829,202 | $-4,658,798 | $-1,070,113 |
| Operating Activities | ||||
| Operating Cash Flow | $-6,849,022 | $-5,648,088 | $-4,542,910 | $-1,009,980 |
| Cash Flow From Continuing Operating Activities | $-6,849,022 | $-5,648,088 | $-4,542,910 | $-1,009,980 |
| Operating Gains Losses | $-266,089 | $-1,665,966 | $1,668,483 | $394,242 |
| Investing Activities | ||||
| Capital Expenditure | $-218,084 | $-181,114 | $-115,888 | $-60,133 |
| Investing Cash Flow | $254,916 | $-1,889,114 | $-115,888 | $-60,133 |
| Cash Flow From Continuing Investing Activities | $254,916 | $-1,889,114 | $-115,888 | $-60,133 |
| Capital Expenditure Reported | $-55,533 | $-51,967 | $-39,982 | $-33,063 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $6,452,887 | $7,042,608 | $6,303,905 | $0 |
| Financing Cash Flow | $6,437,691 | $7,053,571 | $6,474,565 | $1,221,706 |
| Cash Flow From Continuing Financing Activities | $6,437,691 | $7,053,571 | $6,474,565 | $1,221,706 |
| Net Other Financing Charges | $-18,000 | - | $-150,420 | $116,706 |
| Net Common Stock Issuance | $6,452,887 | $7,042,608 | $6,303,905 | $0 |
| Common Stock Issuance | $6,452,887 | $7,042,608 | $6,303,905 | $0 |
| Other | ||||
| Interest Paid Supplemental Data | $8,772 | $8,772 | $179,117 | $2,193 |
| Income Tax Paid Supplemental Data | $0 | $0 | $1,000 | $1,000 |
| End Cash Position | $1,510,065 | $1,659,353 | $2,142,485 | $264,865 |
| Beginning Cash Position | $1,659,353 | $2,142,485 | $264,865 | $115,399 |
| Effect Of Exchange Rate Changes | $7,127 | $499 | $61,853 | $-2,127 |
| Changes In Cash | $-156,415 | $-483,631 | $1,815,767 | $151,593 |
| Proceeds From Stock Option Exercised | $2,804 | $10,963 | $1,131,771 | $0 |
| Net Investment Purchase And Sale | $473,000 | $-1,708,000 | $0 | - |
| Sale Of Investment | $1,708,000 | $0 | - | - |
| Purchase Of Investment | $-1,235,000 | $-1,708,000 | $0 | - |
| Net Intangibles Purchase And Sale | $-22,670 | $-25,374 | $-18,283 | $-27,070 |
| Purchase Of Intangibles | $-22,670 | $-25,374 | $-18,283 | $-27,070 |
| Net PPE Purchase And Sale | $-139,881 | $-103,773 | $-57,623 | $0 |
| Purchase Of PPE | $-139,881 | $-103,773 | $-57,623 | $0 |
| Change In Working Capital | $-5,501 | $192,724 | $405,364 | $3,369,555 |
| Change In Other Current Liabilities | $0 | $-13,650 | $-50,273 | $-46,795 |
| Change In Payables And Accrued Expense | $502,718 | $477,808 | $1,050,627 | $2,855,668 |
| Change In Accrued Expense | $11,635 | $-23,604 | $1,265,361 | $2,685,678 |
| Change In Interest Payable | $11,635 | $-23,604 | $1,265,361 | $2,685,678 |
| Change In Payable | $491,083 | $501,412 | $-214,734 | $169,990 |
| Change In Account Payable | $491,083 | $501,412 | $-214,734 | $169,990 |
| Change In Prepaid Assets | $-19,486 | $-39,423 | $-522,370 | $24,902 |
| Change In Inventory | $-465,837 | $23,405 | $212,747 | $10,126 |
| Change In Receivables | $-22,896 | $-255,416 | $-185,367 | $100,397 |
| Changes In Account Receivables | $-22,896 | $-255,416 | $-185,367 | $100,397 |
| Stock Based Compensation | $456,344 | $3,608,648 | $1,736,174 | $0 |
| Provisionand Write Offof Assets | $251,677 | $0 | $-160,338 | $160,338 |
| Asset Impairment Charge | $0 | $108,424 | $0 | - |
| Depreciation Amortization Depletion | $82,872 | $63,745 | $100,372 | $78,786 |
| Depreciation And Amortization | $82,872 | $63,745 | $100,372 | $78,786 |
| Amortization Cash Flow | $39,548 | $38,502 | $29,157 | $5,118 |
| Amortization Of Intangibles | $39,548 | $38,502 | $29,157 | $5,118 |
| Depreciation | $43,324 | $25,243 | $71,215 | $73,668 |
| Gain Loss On Investment Securities | $-266,089 | $-1,665,966 | $437,003 | $514,925 |
| Net Income From Continuing Operations | $-7,368,325 | $-7,955,663 | $-3,813,800 | $-6,177,784 |
| Repayment Of Debt | - | $0 | $-1,611,111 | $0 |
| Issuance Of Debt | - | $0 | $650,000 | $1,105,000 |
| Net Issuance Payments Of Debt | - | $0 | $-961,111 | $1,105,000 |
| Net Long Term Debt Issuance | - | $0 | $-961,111 | $1,105,000 |
| Long Term Debt Payments | - | $0 | $-1,611,111 | $0 |
| Long Term Debt Issuance | - | $0 | $650,000 | $1,105,000 |
| Change In Other Working Capital | - | - | $-100,000 | $425,257 |
| Other Non Cash Items | - | - | $-4,479,165 | $1,164,883 |
Fetched: 2026-06-18